Interestingly, in patients with non-invasive bladder cancer after resection, the presence of an FGFR3 mutation in cells obtained from urinalysis at routine follow-up was predictive of disease recurrence [49]. The gene discussed is FGFR3; the disease is urinary bladder cancer.